Perjeta® (pertuzumab)
for Breast Cancer

Perjeta (pertuzumab) is a targeted therapy used with trastuzumab and docetaxel to treat HER2-positive breast cancer. As a monoclonal antibody, it works by blocking HER2 receptors, slowing or stopping cancer cell growth.

Heart
Other top medicines used to treat Breast Cancer